Selected research
Industry Research
Antidepressants Industry Research Report 2026
Market perspective
The global Antidepressants market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Antidepressants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Antidepressants is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Antidepressants is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Antidepressants include Bristol-Myers Squibb Company, H Lundbeck, Sun Pharmaceuticals, Astrazeneca, GlaxoSmithKline, Pfizer Inc., Eli Lilly and Company, Merck and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Antidepressants market in terms of revenue (US$ million) and, where applicable, sales volume (W Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/W Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antidepressants Market by Company
Bristol-Myers Squibb Company
H Lundbeck
Sun Pharmaceuticals
Astrazeneca
GlaxoSmithKline
Pfizer Inc.
Eli Lilly and Company
Merck
Johnson & Johnson
Sanofi
Antidepressants Segment by Type
Benzodiazepines
Monoamine Oxidase Inhibitors
Antipsychotics
Tricyclic Antidepressants
Novel Agents
Selective Norepinephrine Reuptake Inhibitors
Selective Serotonin Reuptake Inhibitors
Antidepressants Segment by Application
Hospitals
Clinics
Other
Antidepressants Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antidepressants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antidepressants and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antidepressants.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Antidepressants manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Antidepressants by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Antidepressants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Benzodiazepines
- Monoamine Oxidase Inhibitors
- Antipsychotics
- Tricyclic Antidepressants
- Novel Agents
- Selective Norepinephrine Reuptake Inhibitors
- Selective Serotonin Reuptake Inhibitors
Applications
- Hospitals
- Clinics
- Other
Companies covered
- Bristol-Myers Squibb Company
- H Lundbeck
- Sun Pharmaceuticals
- Astrazeneca
- GlaxoSmithKline
- Pfizer Inc.
- Eli Lilly and Company
- Merck
- Johnson & Johnson
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Antidepressants Market Size (2021-2032)
- 2.2.2 Global Antidepressants Sales (2021-2032)
- 2.2.3 Global Antidepressants Market Average Price (2021-2032)
- 2.3 Antidepressants by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Benzodiazepines
- 2.3.3 Monoamine Oxidase Inhibitors
- 2.3.4 Antipsychotics
- 2.3.5 Tricyclic Antidepressants
- 2.3.6 Novel Agents
- 2.3.7 Selective Norepinephrine Reuptake Inhibitors
- 2.3.8 Selective Serotonin Reuptake Inhibitors
- 2.4 Antidepressants by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospitals
- 2.4.3 Clinics
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Antidepressants Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Antidepressants Sales (W Units) of Manufacturers (2021-2026)
- 3.3 Global Antidepressants Revenue of Manufacturers (2021-2026)
- 3.4 Global Antidepressants Average Price by Manufacturers (2021-2026)
- 3.5 Global Antidepressants Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Antidepressants, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Antidepressants, Product Type & Application
- 3.8 Global Manufacturers of Antidepressants, Established Date
- 3.9 Global Antidepressants Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Bristol-Myers Squibb Company
- 4.1.1 Bristol-Myers Squibb Company Company Information
- 4.1.2 Bristol-Myers Squibb Company Business Overview
- 4.1.3 Bristol-Myers Squibb Company Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Bristol-Myers Squibb Company Antidepressants Product Portfolio
- 4.1.5 Bristol-Myers Squibb Company Recent Developments
- 4.2 H Lundbeck
- 4.2.1 H Lundbeck Company Information
- 4.2.2 H Lundbeck Business Overview
- 4.2.3 H Lundbeck Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 H Lundbeck Antidepressants Product Portfolio
- 4.2.5 H Lundbeck Recent Developments
- 4.3 Sun Pharmaceuticals
- 4.3.1 Sun Pharmaceuticals Company Information
- 4.3.2 Sun Pharmaceuticals Business Overview
- 4.3.3 Sun Pharmaceuticals Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Sun Pharmaceuticals Antidepressants Product Portfolio
- 4.3.5 Sun Pharmaceuticals Recent Developments
- 4.4 Astrazeneca
- 4.4.1 Astrazeneca Company Information
- 4.4.2 Astrazeneca Business Overview
- 4.4.3 Astrazeneca Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Astrazeneca Antidepressants Product Portfolio
- 4.4.5 Astrazeneca Recent Developments
- 4.5 GlaxoSmithKline
- 4.5.1 GlaxoSmithKline Company Information
- 4.5.2 GlaxoSmithKline Business Overview
- 4.5.3 GlaxoSmithKline Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GlaxoSmithKline Antidepressants Product Portfolio
- 4.5.5 GlaxoSmithKline Recent Developments
- 4.6 Pfizer Inc.
- 4.6.1 Pfizer Inc. Company Information
- 4.6.2 Pfizer Inc. Business Overview
- 4.6.3 Pfizer Inc. Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Pfizer Inc. Antidepressants Product Portfolio
- 4.6.5 Pfizer Inc. Recent Developments
- 4.7 Eli Lilly and Company
- 4.7.1 Eli Lilly and Company Company Information
- 4.7.2 Eli Lilly and Company Business Overview
- 4.7.3 Eli Lilly and Company Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Eli Lilly and Company Antidepressants Product Portfolio
- 4.7.5 Eli Lilly and Company Recent Developments
- 4.8 Merck
- 4.8.1 Merck Company Information
- 4.8.2 Merck Business Overview
- 4.8.3 Merck Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Merck Antidepressants Product Portfolio
- 4.8.5 Merck Recent Developments
- 4.9 Johnson & Johnson
- 4.9.1 Johnson & Johnson Company Information
- 4.9.2 Johnson & Johnson Business Overview
- 4.9.3 Johnson & Johnson Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Johnson & Johnson Antidepressants Product Portfolio
- 4.9.5 Johnson & Johnson Recent Developments
- 4.10 Sanofi
- 4.10.1 Sanofi Company Information
- 4.10.2 Sanofi Business Overview
- 4.10.3 Sanofi Antidepressants Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Sanofi Antidepressants Product Portfolio
- 4.10.5 Sanofi Recent Developments
5 Global Antidepressants Market Scenario by Region
- 5.1 Global Antidepressants Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Antidepressants Sales by Region: 2021-2032
- 5.2.1 Global Antidepressants Sales by Region: 2021-2026
- 5.2.2 Global Antidepressants Sales by Region: 2027-2032
- 5.3 Global Antidepressants Revenue by Region: 2021-2032
- 5.3.1 Global Antidepressants Revenue by Region: 2021-2026
- 5.3.2 Global Antidepressants Revenue by Region: 2027-2032
- 5.4 North America Antidepressants Market Facts & Figures by Country
- 5.4.1 North America Antidepressants Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Antidepressants Sales by Country (2021-2032)
- 5.4.3 North America Antidepressants Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Antidepressants Market Facts & Figures by Country
- 5.5.1 Europe Antidepressants Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Antidepressants Sales by Country (2021-2032)
- 5.5.3 Europe Antidepressants Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Antidepressants Market Facts & Figures by Country
- 5.6.1 Asia Pacific Antidepressants Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Antidepressants Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Antidepressants Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Antidepressants Market Facts & Figures by Country
- 5.7.1 South America Antidepressants Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Antidepressants Sales by Country (2021-2032)
- 5.7.3 South America Antidepressants Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Antidepressants Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Antidepressants Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Antidepressants Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Antidepressants Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Antidepressants Sales by Type (2021-2032)
- 6.1.1 Global Antidepressants Sales by Type (2021-2032) & (W Units)
- 6.1.2 Global Antidepressants Sales Market Share by Type (2021-2032)
- 6.2 Global Antidepressants Revenue by Type (2021-2032)
- 6.2.1 Global Antidepressants Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Antidepressants Revenue Market Share by Type (2021-2032)
- 6.3 Global Antidepressants Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Antidepressants Sales by Application (2021-2032)
- 7.1.1 Global Antidepressants Sales by Application (2021-2032) & (W Units)
- 7.1.2 Global Antidepressants Sales Market Share by Application (2021-2032)
- 7.2 Global Antidepressants Revenue by Application (2021-2032)
- 7.2.1 Global Antidepressants Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Antidepressants Revenue Market Share by Application (2021-2032)
- 7.3 Global Antidepressants Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Antidepressants Value Chain Analysis
- 8.1.1 Antidepressants Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Antidepressants Production Mode & Process
- 8.2 Antidepressants Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Antidepressants Distributors
- 8.2.3 Antidepressants Customers
9 Global Antidepressants Analyzing Market Dynamics
- 9.1 Antidepressants Industry Trends
- 9.2 Antidepressants Industry Drivers
- 9.3 Antidepressants Industry Opportunities and Challenges
- 9.4 Antidepressants Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst